Capstone Financial Advisors’s Idexx Laboratories IDXX Stock Holding History

Capstone Financial Advisors’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-455	Closed	-$249K	–	144
2022 Q1	$249K	Buy	455 +47	+12%	+$24.7K	0.02%	107
2021 Q4	$269K	Hold	408	–	–	0.02%	104
2021 Q3	$254K	Hold	408	–	–	0.02%	109
2021 Q2	$258K	Buy	+408	New	+$225K	0.02%	110
2021 Q1	–	Sell	-408	Closed	-$204K	–	135
2020 Q4	$204K	Buy	+408	New	+$183K	0.02%	105

Other funds holding IDXX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return

Capstone Financial Advisors's IDXX Position: Q2 2022 in Review

Capstone Financial Advisors sold out of Idexx Laboratories (IDXX) in Q2 2022, closing a stake of 455 shares — an estimated $249K sold.

Capstone Financial Advisors first reported a position in IDXX in Q4 2020 and held it in 5 quarters. The position peaked at $269K in Q4 2021. 956 funds tracked by Wall St. Rank hold IDXX as of Q2 2022.

Capstone Financial Advisors reported no remaining Idexx Laboratories position as of Q2 2022 after selling out during the quarter.
Capstone Financial Advisors sold 455 Idexx Laboratories shares in Q2 2022, an estimated $249K.
Capstone Financial Advisors first reported a position in Idexx Laboratories in Q4 2020 and held it in 5 quarters.
Capstone Financial Advisors's Idexx Laboratories position peaked at $269K in Q4 2021.
956 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2022.

Based on Capstone Financial Advisors's 13F filing for Q2 2022, filed 2 Sep 2022.